1. Summary Information
|
|
|
Country |
|
|
Company Name |
SUDEEP PHARMA LIMITED |
Principal Name 1 |
Mr. Jaysukh J. Bhayani |
|
Status |
Satisfactory |
Principal Name 2 |
Mr. Sujit J. Bhayani |
|
|
|
Registration # |
04-13141 |
|
Street Address |
129/ 1/ A, G.I.D.C. Estate, Nandesari, Vadodara – 391 340, |
||
|
Established Date |
21.12.1989 |
SIC Code |
-- |
|
Telephone# |
91-265-2840656 / 3291354 |
Business Style 1 |
Manufacturer |
|
Fax # |
91-265-2841250 / 2336284 |
Business Style 2 |
-- |
|
Homepage |
Product Name 1 |
Pharmaceutical |
|
|
# of employees |
Approximately 200 (In office – 20 and In Factory – 165 ) |
Product Name 2 |
Food |
|
Paid up capital |
Rs. 12,681,000/- |
Product Name 3 |
Feed Ingredients |
|
Shareholders |
Directors or relatives of directors (100.00%) |
Banking |
Bank of |
|
Public Limited Corp. |
NO |
Business Period |
22 Years |
|
IPO |
NO |
International Ins. |
- |
|
Public |
NO |
Rating |
Ba (46) |
|
Related
Company |
|||
|
Relation
|
Country
|
Company
Name |
CEO |
|
Note |
- |
||
2. Summary
Financial Statement
|
Balance Sheet as of |
31.03.2010 |
(Unit: Indian Rs.) |
|
|
Assets |
Liabilities |
||
|
Current Assets |
40,505,000 |
Current Liabilities |
18,358,000 |
|
Inventories |
14,203,000 |
Long-term Liabilities |
33,685,000 |
|
Fixed Assets |
61,835,000 |
Other Liabilities |
16,378,000 |
|
Deferred Assets |
000 |
Total Liabilities |
68,421,000 |
|
Invest& other Assets |
721,000 |
Retained Earnings |
36,162,000 |
|
|
|
Net Worth |
48,843,000 |
|
Total Assets |
117,264,000 |
Total Liab. & Equity |
117,264,000 |
|
Total Assets (Previous Year) |
110,879,000 |
|
|
|
P/L Statement as of |
31.03.2010 |
(Unit: Indian Rs.) |
|
|
Sales |
223,560,000 |
Net Profit |
31,905,000 |
|
Sales(Previous yr) |
237,459,000 |
Net Profit(Prev.yr) |
18,995,000 |
MIRA
INFORM REPORT
|
Report Date : |
08.08.2011 |
IDENTIFICATION DETAILS
|
Name : |
SUDEEP PHARMA LIMITED |
|
|
|
|
Registered Office : |
129/ 1/ A, G.I.D.C. Estate, Nandesari, Vadodara – 391 340, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.03.2009 |
|
|
|
|
Date of Incorporation : |
21.12.1989 |
|
|
|
|
Com. Reg. No.: |
04-13141 |
|
|
|
|
Capital Investment/
Paid-up Capital: |
Rs.12.681
millions |
|
|
|
|
CIN No.: [Company
Identification No.] |
U24231GJ1989PLC013141 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
BRDS02074C |
|
|
|
|
PAN No.: [Permanent
Account No.] |
AACCS9716J |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company. |
|
|
|
|
Line of Business : |
Manufacturer of Pharmaceutical, Food and Feed Ingredients. |
|
|
|
|
No. of Employees: |
Approximately 200 (In office – 20 and In Factory – 165 ) |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (46) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 190000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having satisfactory track. Trade relations
are reported as fair. Business is active. Payments are reported to be usually
correct and as per commitments. The company can be considered normal for business dealings at usual
trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – April 1, 2010
|
Country Name |
Previous Rating (31.12.2009) |
Current Rating (01.04.2010) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INFORMATION PARTED BY
|
Name : |
Mr. Sujit J Bhayani |
|
Designation : |
Director |
|
Contact No.: |
91-9376216351 |
LOCATIONS
|
Registered Office : |
129/ 1/ A, G.I.D.C. Estate, Nandesari, Vadodara – 391 340, |
|
Tel. No.: |
91-265-2840656 / 3291354 |
|
Fax No.: |
91-265-2841250 / 2336284 |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
100000 Sq. Fts |
|
Location : |
Owned |
|
|
|
|
Factory : |
D/307 Kailash Complex, |
|
Tel. No.: |
91-22-25185766 / 67254281 |
|
Fax No. : |
91-22-25185766 |
|
E-Mail : |
|
|
Area : |
600 Sq. Ft. |
|
Location : |
Owned |
DIRECTORS
As on 27.09.2010
|
Name : |
Mr. Jaysukh J. Bhayani |
|
Designation : |
Managing Director |
|
Address : |
66, Kunj Society, Alkapuri, Vadodara – 390 005, |
|
Date of Birth/Age : |
23.07.1941 |
|
Date of Appointment : |
21.10.1992 |
|
|
|
|
Name : |
Mr. Sujit J. Bhayani |
|
Designation : |
Director |
|
Address : |
66, Kunj Society, Alkapuri, Vadodara – 390 005, |
|
Date of Birth/Age : |
28.06.1967 |
|
Date of Appointment : |
01.03.1995 |
|
|
|
|
Name : |
Mr. Rajendra C Patel |
|
Designation : |
Director |
|
Address : |
303 Ramkrishna Flats Alkapuri, Vadodara, |
|
Date of Birth/Age : |
12.09.1945 |
|
Date of Appointment : |
01.02.2009 |
|
|
|
|
Name : |
Mr. Vishal Rakesh Agrawal |
|
Designation : |
Director |
|
Address : |
61, Alkapur Society, Alkapuri, Vadodar-390005, |
|
Date of Birth/Age : |
01.10.1974 |
|
Date of Appointment : |
01.04.2011 |
|
DIN No.: |
00056800 |
KEY EXECUTIVES
|
Name : |
Ms. Bhavna Desai |
|
Designation : |
Executive Director |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 27.09.2010
|
Names of Shareholders |
|
No. of Shares |
|
Mr. Jaysukh J. Bhayani |
|
147780 |
|
Mr. Sujit Bhayani |
|
147600 |
|
J. J. Bhayani – H.U.F. |
|
112500 |
|
Mrs. Avani S. Bhayani |
|
180000 |
|
Sujit Bhayani H.U.F. |
|
231250 |
|
|
|
|
|
Anjana R. Patel Shanil S Bhayani |
|
84000 |
|
|
|
|
|
Sujit J. Bhayani Avani S. Bhayani |
|
286250 |
|
|
|
|
|
Avani S. Bhayani Sujit J. Bhayani |
|
54720 |
|
|
|
|
|
Rajendra C. Patel Shanil S. Bhayani |
|
20000 |
|
|
|
|
|
Shanil S. Bhayani Sujit J. Bhayani |
|
2000 |
|
|
|
|
|
Rhea S. Bhayani Sujit J. Bhayani |
|
2000 |
|
|
|
|
|
Total |
|
1268100 |
Equity Share Breakup (Percentage of Total
Equity)
as ON 30.09.2010
|
Category |
|
Percentage of Holding |
|
|
|
|
|
Directors
or relatives of directors |
|
100.00 |
|
|
|
|
|
Total |
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of Pharmaceutical, Food and Feed Ingredients. |
||||
|
|
|
||||
|
Products : |
|
PRODUCTION STATUS AS ON (31.03.2010)
|
Particulars |
Unit |
|
|
Installed
Capacity |
|
DCP/TCP/MM etc. (Pharma Products) |
Kgs |
|
|
6000000 |
GENERAL INFORMATION
|
Customers : |
|
|
|
|
|
No. of Employees : |
Approximately 200 (In office – 20 and In Factory – 165 ) |
|
|
|
|
Bankers : |
Bank of |
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Shah Mehta and Bakshi Chartered Accountants |
|
Address : |
Prasanna House, Associated Opposite Radhakrishna, Near Akota Stadium,
Vadodara – 390 020, |
|
Tel No. : |
91-265-2331060/ 2337727/ 2355435 |
|
Fax No. : |
91-265-2654630/ 2343227 |
|
Email : |
CAPITAL STRUCTURE
As on 30.03.2009-
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
6000000 |
Equity Shares |
Rs.10/- each |
Rs.60.000 millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
1268100 |
Equity Shares |
Rs.10/- each
|
Rs.12.681
millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE SHEET
|
SOURCES OF FUNDS |
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
12.681 |
12.681 |
12.681 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
36.162 |
32.560 |
13.066 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
48.843 |
45.241 |
25.747 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
30.654 |
35.427 |
23.605 |
|
|
2] Unsecured Loans |
3.031 |
1.348 |
5.666 |
|
|
TOTAL BORROWING |
33.685 |
36.775 |
29.271 |
|
|
DEFERRED TAX LIABILITIES |
3.227 |
3.033 |
2.302 |
|
|
|
|
|
|
|
|
TOTAL |
85.755 |
85.049 |
57.320 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
61.835 |
51.364 |
32.202 |
|
|
Capital work-in-progress |
0.024 |
0.000 |
3.439 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.000 |
0.000 |
0.100 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
14.203
|
16.400
|
11.490
|
|
|
Sundry Debtors |
32.214
|
31.575
|
14.049
|
|
|
Cash & Bank Balances |
0.110
|
0.057
|
0.016
|
|
|
Other Current Assets |
8.181
|
10.438
|
9.782
|
|
|
Loans & Advances |
0.000
|
0.000
|
0.000
|
|
Total
Current Assets |
54.708
|
58.470
|
35.337 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
16.060
|
17.063
|
12.293 |
|
|
Other Liabilities |
2.298
|
2.008
|
2.858 |
|
|
Provisions |
13.151
|
6.759
|
0.000 |
|
Total
Current Liabilities |
31.509
|
25.830
|
15.151
|
|
|
Net Current Assets |
23.199
|
32.640
|
20.186
|
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.697 |
1.045 |
1.393 |
|
|
|
|
|
|
|
|
TOTAL |
85.755 |
85.049 |
57.320 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
223.560 |
237.459 |
126.959 |
|
|
|
Other Income |
0.812 |
0.049 |
0.000 |
|
|
|
TOTAL (A) |
224.372 |
237.508 |
126.959 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Raw material Consumed |
101.855 |
144.216 |
78.039 |
|
|
|
Increase/ Decrease in finished goods, work in progress |
6.418 |
[4.364] |
[3.805] |
|
|
|
Salaries, wages and bonus |
10.232 |
7.041 |
0.000 |
|
|
|
Managerial Remuneration |
3.000 |
2.940 |
0.000 |
|
|
|
Payment to auditors |
0.239 |
0.243 |
0.216 |
|
|
|
Insurance Expenses |
0.340 |
0.326 |
0.249 |
|
|
|
Power and Fuel |
9.722 |
10.686 |
6.423 |
|
|
|
Other Expenditure |
38.265 |
37.772 |
39.010 |
|
|
|
TOTAL (B) |
170.071 |
198.860 |
120.132 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
54.301 |
38.648 |
6.827 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES/ INTEREST (D) |
3.424 |
4.057 |
0.000 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
50.877 |
34.591 |
6.827 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
4.633 |
3.852 |
3.782 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX (E-F) (G) |
46.244 |
30.739 |
3.045 |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
14.339 |
11.744 |
1.162 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
(G-H) (I) |
31.905 |
18.995 |
1.883 |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
|
|
|
|
|
|
|
Export Earnings |
124.901 |
140.104 |
37.522 |
|
|
TOTAL EARNINGS |
124.901 |
140.104 |
37.522 |
|
|
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
|
|
Import Value |
41.858 |
26.480 |
12.328 |
|
|
TOTAL IMPORTS |
41.858 |
26.480 |
12.328 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
25.16 |
14.98 |
1.48 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
PAT / Total Income |
(%) |
14.22 |
7.98 |
1.48
|
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
20.69
|
12.94
|
2.39 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
39.68 |
27.99 |
4.51
|
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.95 |
0.68 |
0.12
|
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
1.33 |
1.38 |
1.73
|
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.74 |
2.26 |
2.33
|
LOCAL AGENCY FURTHER INFORMATION
change of address:-
The registered office of the company has been shifted from 66, Kunj Society, Alkapuri, Vadodara – 390 005,
Bankers Charges
Report as per Registry
|
Corporate
identity number of the company |
U24231GJ1989PLC013141 |
|
Name of the
company |
SUDEEP PHARMA LIMITED |
|
Address of the
registered office or of the principal place of business in |
129/ 1/ A, G.I.D.C. Estate, Nandesari, Vadodara – 391 340, |
|
This form is for |
Creation of
Charge |
|
Type of charge |
Movable Property |
|
Particular of
charge holder |
Bank of E-Mail: indnan@bankofbaroda.com |
|
Nature of
instrument creating charge |
Instrument of
Hypothecation of Vehicles |
|
Date of
instrument Creating the charge |
21.09.2010 |
|
Amount secured by
the charge |
Rs. 3.860
Millions |
|
Brief of the principal
terms an conditions and extent and operation of the charge |
Rate of Interest At the Rate of
1.75% over baser rate of the bank per annum with monthly rest on the last day
of each month. Terms of
Repayment The loan shall be
repaid in 60 equal monthly installment of Rs. 0.082 Million. First
installment to commence 1 months form the date of first disbursement Margin 10% on total
cost. Extent and
Operation of the charge The borrower doth
hereby hypothecation by way of first charge in favour of the bank all the
said vehicles as a security fore due repayment to the Bank of the said loan |
|
Short particulars
of the property charged |
4- Wheeler,
Model- Audi QS 2.0 TFSI (CBU) |
|
This form is for |
Modification of charge
|
|
Charge
identification number of the modified |
90103900 |
|
Corporate
identity number of the company |
U24231GJ1989PLC013141 |
|
Name of the
company |
SUDEEP PHARMA LIMITED |
|
Address of the
registered office or of the principal place of business in |
66, Kunj Society, Alkapuri, Vadodara – 390 005, |
|
Type of charge |
Immovable
Property |
|
Particular of
charge holder |
Bank of E-Mail: indnan@bankofbaroda.com |
|
Nature of
description of the instrument creating or modifying the charge |
Instrument
relating to release and redeposit of title deeds. |
|
Date of instrument
Creating the charge |
03.02.2009 |
|
Amount secured by
the charge |
Rs.37.415
millions |
|
Brief particulars
of the principal terms an conditions and extent and operation of the charge |
Rate of Interest:
As per Agreement. Terms of Repayment:
As per Agreement. Margin: As per
Agreement. Extent and
Operation of the charge: As per Agreement.
|
|
Short particulars
of the property charged |
Leasehold
Immovable property bearing P. No.129/ 1/ A adm. 3024 sq mts. In Nandesari
Industrial Estate bearing S. No.528525 and 520 within Nandesari, P. Shed No.
C-1/ B/ 129/ 12 in NIA bearing RS. No.530/ P adm. 608 sq mts. Within
Nandesari, P. No. C – 1/ B/ 129/ 13 in NIA bearing RS No.530/ P adm. 749.88
sq mts. And P. No.129/ 15 in NIA bearing RS. No.514/ P, 530/ P adm. 608 sq
mts. Within Nandesari. |
|
Date of latest
modification prior to the present modification |
14.03.2008 |
|
Particulars of
the present modification |
Over and above properties
mentioned of this form, deposit of title deeds for lease hold immovable
property at Plot 129/ 15 on land bearing R.S. No.514/ P and 530/ P, Village
Nandesari adm. 608.00 sq mts. For securing enhanced facilities from Rs.25.242
millions to Rs.37.415 millions. |
FIXED ASSETS:-
- Land
Leasehold
- Office –
Mumbai
- Factory Shed
- Plant and
Machinery
- Laboratory
Equipment
- Computer
- Vehicles
- Office
Equipments
- Miscellaneous
Fixed Assets
- Furniture and
Fixtures
WEBSITE DETAILS:-
PROFILE:
Subject established in 1989 for the production of Pharmaceutical, Food
and Feed ingredients. The major products are various kinds of Calcium
Phosphates, with annual capacities 10,000 MT. They are the largest manufacturer
and exporter catering to the requirements of over 600 content customers around
the globe. The regular exports are to
All products are manufactured under standards of good manufacturing
practice (GMP) and comply with various international official compendia such as
The United States Pharmacopeia / National Formulary (USP/NF), The European
Pharmacopeia (EP) and the British Pharmacopeia (BP)
Quality is one of the most important aspects in the corporate
philosophy. They have a strict procedure in place to ensure consistent
production and quality. It all begins with raw material testing, procured from
approved suppliers leading to the stages of production and ends with timely
dispatches.
The highly trained and motivated employees are an integral link of the
production chain. The professionalism and high standards in all departments has
resulted in a world wide acceptance of the products.
PRODUCTS:
Calcium and Phosphorous are two very essential minerals for a HEALTHY
BODY. There is an ever increasing demand for Calcium Phosphates due to the
awareness of its benefits. Medical professionals and Health conscious consumers
understand its nutritional value, with the major role it plays in maintaining
healthy bones and fighting osteoporosis. Recently research in the
Calcium phosphates
are an important excipient used as a diluent and filler in Pharma and food
industries because of its inherent characters of compatibility with most of the
active ingredients.
· Di Calcium Phosphate Dihydrate
· Di Calcium Phosphate Anhydrous
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper payments
to government officials for engaging in prohibited transactions or with
designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l Anti-Money
Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws, regulations
or policies that prohibit, restrict or otherwise affect the terms and
conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 44.80 |
|
|
1 |
Rs. 72.86 |
|
Euro |
1 |
Rs. 63.11 |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
6 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
5 |
|
--PROFITABILIRY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
---- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
46 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.